California-based Amgen recently became the eighth pharmaceutical manufacturer to expand its 340B claims data requirements to in-house pharmacy use—and the [...] The post Amgen is 8th Drugmaker to Announce 340B In-House Pharmacy Data Requirements, First to Seek Healthcare Service Data appeared first on 340B Report.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.